A peptide fragment of histone H3
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Histone H3K36Me3 (31-41) (trifluoroacetate salt)

Item No. 28145

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
L-seryl-L-threonyl-L-glycyl-L-glycyl-L-valyl-L-6-(trimethylammonio)-L-norlysyl-L-prolyl-L-histidyl-L-arginine, trifluoroacetate salt
Synonyms
  • Histone H3 (31-41) (Lys36me3)
  • [Lys(Me3)36]-Histone H3 (31-41)
  • STGGV-K(Me3)-KPHRY
Molecular Formula
C57H94N18O15 • XCF3COOH
Formula Weight
1271.5
Purity
≥95%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
Water: 1 mg/ml
SMILES
C[N+](CCCC[C@H](NC([C@@H](NC(CNC(CNC([C@@]([H])(NC([C@@H](N)CO)=O)[C@H](O)C)=O)=O)=O)C(C)C)=O)C(N[C@H](C(N1CCC[C@H]1C(N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@@H](CC3=CC=C(C=C3)O)C([O-])=O)=O)CCCNC(N)=N)=O)=O)=O)CCCCN)=O)(C)C.O=C(O)C(F)(F)F
InChi Code
InChI=1S/C57H94N18O15.C2HF3O2/c1-32(2)46(72-45(80)29-64-44(79)28-65-53(86)47(33(3)77)73-48(81)37(59)30-76)54(87)68-38(13-8-10-24-75(4,5)6)49(82)69-40(14-7-9-21-58)55(88)74-23-12-16-43(74)52(85)70-41(26-35-27-62-31-66-35)51(84)67-39(15-11-22-63-57(60)61)50(83)71-42(56(89)90)25-34-17-19-36(78)20-18-34;3-2(4,5)1(6)7/h17-20,27,31-33,37-43,46-47,76-77H,7-16,21-26,28-30,58-59H2,1-6H3,(H15-,60,61,62,63,64,65,66,67,68,69,70,71,72,73,78,79,80,81,82,83,84,85,86,87,89,90);(H,6,7)/t33-,37+,38+,39+,40+,41+,42+,43+,46+,47+;/m1./s1
InChi Key
IBIRQNRJDPWSCC-VEMPTVKDSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $369

    Add
    Product Description

    Histone H3K36Me3 (31-41) is a peptide fragment of histone H3 that corresponds to amino acid residues 32-42 of the human histone H3.3 sequence. Unlike histone H3.1 and H3.2, the histone H3.3 variant contains a serine residue at position 31 that is phosphorylated during late prometaphase and metaphase of mitosis.1 Trimethylation of H3K36 is increased in the G1 and early S phases of the cell cycle where it binds to and recruits the mismatch recognition protein MutSα in preparation for DNA replication and mismatch repair.2 H3K36 trimethylation is found in greater amounts on exons compared with introns in C. elegans, mouse, and human genome-wide maps of histone H3 tail methylations.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hake, S.B., Garcia, B.A., Kauer, M., et al. Serine 31 phosphorylation of histone variant H3.3 is specific to regions bordering centromeres in metaphase chromosomes. Proc. Natl. Acad. Sci. USA 102(18), 6344-6349 (2005).

    2. Li, F., Mao, G., Tong, D., et al. The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSα. Cell 153(3), 590-600 (2013).

    3. Kolasinska-Zwierz, P., Down, T., Latorre, I., et al. Differential chromatin marking of introns and expressed exons by H3K36me3. Nat. Genet. 41(3), 376-381 (2009).